Kevin E. Noonan

1.5k total citations · 1 hit paper
11 papers, 1.3k citations indexed

About

Kevin E. Noonan is a scholar working on Molecular Biology, Oncology and Management of Technology and Innovation. According to data from OpenAlex, Kevin E. Noonan has authored 11 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Management of Technology and Innovation. Recurrent topics in Kevin E. Noonan's work include Cancer therapeutics and mechanisms (3 papers), Intellectual Property and Patents (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Kevin E. Noonan is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Intellectual Property and Patents (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Kevin E. Noonan collaborates with scholars based in United States and Latvia. Kevin E. Noonan's co-authors include Igor B. Roninson, Janice E. Chin, Christian Beck, Adi F. Gazdar, Barbara Griffith, Irene L. Andrulis, Daniel D. Von Hoff, Jay S. Wunder, Cheryl L. Willman and Tatyana A. Holzmayer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Kevin E. Noonan

9 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.

1990 660 citations Kevin E. Noonan, Christian Beck et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin E. Noonan United States	7	711	643	194	155	123	11	1.3k
Tatyana A. Holzmayer United States	7	609 0.9×	595 0.9×	174 0.9×	74 0.5×	69 0.6×	10	1.0k
Zheng Ge China	27	346 0.5×	1.5k 2.4×	136 0.7×	178 1.1×	131 1.1×	134	2.4k
Sarah L. Hunt United Kingdom	14	521 0.7×	1.4k 2.2×	83 0.4×	167 1.1×	133 1.1×	16	2.0k
Lotte K. Vogel Denmark	27	485 0.7×	772 1.2×	148 0.8×	448 2.9×	311 2.5×	59	2.0k
Cheng‐Wen Wu Taiwan	25	445 0.6×	1.0k 1.6×	81 0.4×	85 0.5×	171 1.4×	51	1.7k
Christopher S. Nabel United States	16	511 0.7×	1.1k 1.7×	98 0.5×	258 1.7×	166 1.3×	26	1.9k
Ji Zhao United States	15	155 0.2×	926 1.4×	142 0.7×	86 0.6×	110 0.9×	21	1.6k
Göran Holm Sweden	25	398 0.6×	522 0.8×	127 0.7×	62 0.4×	146 1.2×	53	2.6k
A.P.M. Jongsma Netherlands	15	451 0.6×	609 0.9×	179 0.9×	60 0.4×	207 1.7×	27	1.5k
Chih-Wei Lin Taiwan	16	156 0.2×	534 0.8×	112 0.6×	180 1.2×	109 0.9×	29	1.5k

Countries citing papers authored by Kevin E. Noonan

Since Specialization

Citations

This map shows the geographic impact of Kevin E. Noonan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin E. Noonan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin E. Noonan more than expected).

Fields of papers citing papers by Kevin E. Noonan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin E. Noonan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin E. Noonan. The network helps show where Kevin E. Noonan may publish in the future.

Co-authorship network of co-authors of Kevin E. Noonan

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin E. Noonan. A scholar is included among the top collaborators of Kevin E. Noonan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin E. Noonan. Kevin E. Noonan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Noonan, Kevin E.. (2018). Personalized Medicine and Patient Privacy Concerns in the Telemedicine Age. The Institutional Repository at DePaul University (DePaul University). 19(3). 1. 1 indexed citations

2.

Noonan, Kevin E.. (2015). The Role of Regulatory Agencies and Intellectual Property: Part II. Cold Spring Harbor Perspectives in Medicine. 5(7). a020834–a020834. 1 indexed citations

3.

Noonan, Kevin E.. (2015). The Role of Regulatory Agencies and Intellectual Property: Part I. Cold Spring Harbor Perspectives in Medicine. 5(7). a020800–a020800. 1 indexed citations

4.

Ostrer, Harry, J.S. Hendricks, & Kevin E. Noonan. (2013). Association for Molecular Pathology v. Myriad Genetics, Inc.. 15 indexed citations

5.

Offit, Kenneth, Angela R. Bradbury, Courtney D. Storm, et al.. (2013). Gene Patents and Personalized Cancer Care: Impact of the Myriad Case on Clinical Oncology. Journal of Clinical Oncology. 31(21). 2743–2748. 43 indexed citations

6.

Noonan, Kevin E.. (2011). ON INTELLECTUAL PROPERTY. Chemical & Engineering News. 89(6). 34–35.

7.

Chumakov, Konstantin, et al.. (1991). Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine.. Proceedings of the National Academy of Sciences. 88(1). 199–203. 118 indexed citations

8.

Noonan, Kevin E., Christian Beck, Tatyana A. Holzmayer, et al.. (1990). Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.. Proceedings of the National Academy of Sciences. 87(18). 7160–7164. 660 indexed citations breakdown →

9.

Chin, Janice E., et al.. (1989). Structure and Expression of the Human MDR (P-Glycoprotein) Gene Family. Molecular and Cellular Biology. 9(9). 3808–3820. 54 indexed citations

10.

Chin, Janice E., et al.. (1989). Structure and expression of the human MDR (P-glycoprotein) gene family.. Molecular and Cellular Biology. 9(9). 3808–3820. 248 indexed citations

11.

Noonan, Kevin E. & Igor B. Roninson. (1988). mRNA phenotyping by enzymatic amplification of randomly primed cDNA. Nucleic Acids Research. 16(21). 10366–10366. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact